4//SEC Filing
Merck & Co. Inc. 4
Accession 0001225208-14-004114
$MRKCIK 0000310158operating
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 5:07 PM ET
Size
9.3 KB
Accession
0001225208-14-004114
Insider Transaction Report
Form 4
Canan John
Senior V-P, Controller
Transactions
- Sale
Common Stock
2014-02-11$55.70/sh−10,000$557,002→ 10,696.576 total - Exercise/Conversion
Common Stock
2014-02-11$48.24/sh+10,000$482,400→ 20,696.576 total - Exercise/Conversion
Stock Option (right to buy)
2014-02-11−10,000→ 0 totalExercise: $48.24From: 2005-02-27Exp: 2014-02-26→ Common Stock (10,000 underlying)
Holdings
- 3,345.974(indirect: By 401(k))
Common Stock - 401(k) Plan
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.68 to $55.72, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
- [F2]Holdings include shares acquired in dividend reinvestment transactions.
- [F3]Includes shares acquired and dividends through January 8, 2014, in the Merck U.S. Savings Plan, a 401(k) plan.
Documents
Issuer
Merck & Co. Inc.
CIK 0000310158
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000310158
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 5:07 PM ET
- Size
- 9.3 KB